Nexalin Technology taps Robert DiTota for global commercialization strategy advisory role
Nexalin Technology (NXLIW) says it has tapped neuromodulation commercial executive Robert DiTota to advise on its global commercialization strategy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.